The impact of COVID-19 on the cancer care of adolescents and young adults and their well-being: Results from an online survey conducted in the early stages of the pandemic.
adolescent cancer
anxiety
coronavirus disease 2019 (COVID-19)
depression
information needs
survey
young adult cancer
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
15
05
2020
revised:
27
06
2020
accepted:
29
06
2020
pubmed:
23
7
2020
medline:
18
12
2020
entrez:
23
7
2020
Statut:
ppublish
Résumé
Because of the global spread of coronavirus disease 2019 (COVID-19), oncology departments across the world have rapidly adapted their cancer care protocols to balance the risk of delaying cancer treatments and the risk of COVID-19 exposure. COVID-19 and associated changes may have an impact on the psychosocial functioning of patients with cancer and survivors. This study was designed to determine the impact of the COVID-19 pandemic on young people living with and beyond cancer. In this cross-sectional study, 177 individuals, aged 18 to 39 years, were surveyed about the impact of COVID-19 on their cancer care and psychological well-being. Participants also reported their information needs with respect to COVID-19. Responses were summarized with a content analysis approach. This was the first study to examine the psychological functioning of young patients and survivors during the first weeks of the COVID-19 pandemic. A third of the respondents reported increased levels of psychological distress, and as many as 60% reported feeling more anxious than they did before COVID-19. More than half also wanted more information tailored to them as young patients with cancer. The COVID-19 pandemic is rapidly evolving and changing the landscape of cancer care. Young people living with cancer are a unique population and might be more vulnerable during this time in comparison with their healthy peers. There is a need to screen for psychological distress and attend to young people whose cancer care has been delayed. As the lockdown begins to ease, the guidelines about cancer care should be updated according to this population's needs.
Sections du résumé
BACKGROUND
Because of the global spread of coronavirus disease 2019 (COVID-19), oncology departments across the world have rapidly adapted their cancer care protocols to balance the risk of delaying cancer treatments and the risk of COVID-19 exposure. COVID-19 and associated changes may have an impact on the psychosocial functioning of patients with cancer and survivors. This study was designed to determine the impact of the COVID-19 pandemic on young people living with and beyond cancer.
METHODS
In this cross-sectional study, 177 individuals, aged 18 to 39 years, were surveyed about the impact of COVID-19 on their cancer care and psychological well-being. Participants also reported their information needs with respect to COVID-19. Responses were summarized with a content analysis approach.
RESULTS
This was the first study to examine the psychological functioning of young patients and survivors during the first weeks of the COVID-19 pandemic. A third of the respondents reported increased levels of psychological distress, and as many as 60% reported feeling more anxious than they did before COVID-19. More than half also wanted more information tailored to them as young patients with cancer.
CONCLUSIONS
The COVID-19 pandemic is rapidly evolving and changing the landscape of cancer care. Young people living with cancer are a unique population and might be more vulnerable during this time in comparison with their healthy peers. There is a need to screen for psychological distress and attend to young people whose cancer care has been delayed. As the lockdown begins to ease, the guidelines about cancer care should be updated according to this population's needs.
Identifiants
pubmed: 32697342
doi: 10.1002/cncr.33098
pmc: PMC7405129
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4414-4422Subventions
Organisme : NIHR Oxford Health Biomedical Research Centre
Pays : International
Organisme : National Institute for Health Research
ID : DRF-2016-09-021
Pays : International
Organisme : MQ
Pays : International
Informations de copyright
© 2020 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.
Références
JAMA Netw Open. 2018 Jun 1;1(2):e180350
pubmed: 30646082
Cancer. 2020 Jul 15;126(14):3281-3288
pubmed: 32365227
JAMA. 2020 May 26;323(20):2005-2006
pubmed: 32282023
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
Pediatr Blood Cancer. 2020 Jul;67(7):e28318
pubmed: 32240567
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
Psychooncology. 2019 Feb;28(2):284-292
pubmed: 30414219
JAMA Pediatr. 2016 May 1;170(5):495-501
pubmed: 26999630
Psychooncology. 2020 Jan;29(1):17-37
pubmed: 31692183
Psychol Med. 2019 Jan;49(2):268-277
pubmed: 29684289
Cancer. 2020 Oct 1;126(19):4414-4422
pubmed: 32697342
JAMA Intern Med. 2020 Jun 1;180(6):817-818
pubmed: 32275292
JMIR Res Protoc. 2018 Aug 29;7(8):e168
pubmed: 30158103
JAMA Oncol. 2020 Sep 1;6(9):1459-1460
pubmed: 32401276
J Cancer Surviv. 2020 Oct;14(5):601-606
pubmed: 32335850
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Lancet Oncol. 2009 Jun;10(6):589-97
pubmed: 19482247
Psychooncology. 2013 Jan;22(1):1-11
pubmed: 22232030
J Pediatr Hematol Oncol. 2014 Oct;36(7):545-51
pubmed: 24390448
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Nat Med. 2020 May;26(5):665-671
pubmed: 32405058
JCO Glob Oncol. 2020 Apr;6:557-559
pubmed: 32250659
J Cancer Surviv. 2016 Oct;10(5):814-31
pubmed: 26920873
J Adolesc Young Adult Oncol. 2020 Apr;9(2):289-294
pubmed: 31747327
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714